Vitamin D increases glucocorticoid efficacy via inhibition of mTORC1 in experimental models of multiple sclerosis.
Animals
Anti-Inflammatory Agents
/ pharmacology
Calcitriol
/ pharmacology
Encephalomyelitis, Autoimmune, Experimental
/ immunology
Glucocorticoids
/ pharmacology
Humans
Mechanistic Target of Rapamycin Complex 1
/ metabolism
Mice
Multiple Sclerosis
Receptors, Glucocorticoid
/ drug effects
Signal Transduction
/ physiology
T-Lymphocytes
/ drug effects
Calcitriol
Mammalian target of rapamycin
Relapse treatment
Steroid resistance
c-Jun N-terminal kinase
Journal
Acta neuropathologica
ISSN: 1432-0533
Titre abrégé: Acta Neuropathol
Pays: Germany
ID NLM: 0412041
Informations de publication
Date de publication:
09 2019
09 2019
Historique:
received:
07
12
2018
accepted:
20
04
2019
revised:
31
03
2019
pubmed:
29
4
2019
medline:
7
8
2020
entrez:
29
4
2019
Statut:
ppublish
Résumé
The limited efficacy of glucocorticoids (GCs) during therapy of acute relapses in multiple sclerosis (MS) leads to long-term disability. We investigated the potential of vitamin D (VD) to enhance GC efficacy and the mechanisms underlying this VD/GC interaction. In vitro, GC receptor (GR) expression levels were quantified by ELISA and induction of T cell apoptosis served as a functional readout to assess synergistic 1,25(OH)
Identifiants
pubmed: 31030237
doi: 10.1007/s00401-019-02018-8
pii: 10.1007/s00401-019-02018-8
pmc: PMC6689294
doi:
Substances chimiques
Anti-Inflammatory Agents
0
Glucocorticoids
0
Receptors, Glucocorticoid
0
Mechanistic Target of Rapamycin Complex 1
EC 2.7.11.1
Calcitriol
FXC9231JVH
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
443-456Subventions
Organisme : Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
ID : 310030_172952
Pays : International
Organisme : National Health and Medical Research Council
ID : 1032486
Pays : International
Organisme : NHRMC
ID : 1080518
Pays : International
Références
Brain. 2000 Jul;123 ( Pt 7):1431-41
pubmed: 10869055
Arch Neurol. 2001 Jan;58(1):91-7
pubmed: 11176941
Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13681-6
pubmed: 11717429
Neurology. 2003 Dec 9;61(11):1528-32
pubmed: 14663037
Ann N Y Acad Sci. 2004 Jun;1024:138-46
pubmed: 15265778
J Clin Invest. 2006 Jan;116(1):146-55
pubmed: 16341266
Nervenarzt. 2006 Apr;77(4):430-8
pubmed: 16341736
Cancer Cell Int. 2007 Mar 28;7:3
pubmed: 17391526
N Engl J Med. 2007 Jul 19;357(3):266-81
pubmed: 17634462
J Bone Miner Res. 2007 Nov;22(11):1668-71
pubmed: 17645404
World J Gastroenterol. 2008 Jan 14;14(2):200-2
pubmed: 18186555
J Neurol. 2008 Feb;255(2):280-7
pubmed: 18204919
Biochem J. 2008 Jun 1;412(2):179-90
pubmed: 18466115
J Immunol. 2008 Jun 15;180(12):8434-43
pubmed: 18523311
Mult Scler. 2008 Aug;14(7):919-26
pubmed: 18573821
Proc Natl Acad Sci U S A. 2009 Mar 31;106(13):5276-81
pubmed: 19282478
Lancet. 2009 May 30;373(9678):1905-17
pubmed: 19482216
Crit Rev Immunol. 2009;29(3):255-73
pubmed: 19538138
PLoS One. 2009 Dec 07;4(12):e8202
pubmed: 19997594
J Allergy Clin Immunol. 2010 May;125(5):995-1000
pubmed: 20381849
Mayo Clin Proc. 2010 Aug;85(8):752-7; quiz 757-8
pubmed: 20675513
FASEB J. 2011 Mar;25(3):937-47
pubmed: 21123297
Nat Immunol. 2011 Apr;12(4):295-303
pubmed: 21358638
J Neuroinflammation. 2011 May 24;8:56
pubmed: 21605467
J Neuroendocrinol. 2012 Jan;24(1):174-82
pubmed: 21615563
J Clin Endocrinol Metab. 2012 Aug;97(8):E1402-10
pubmed: 22659246
Neurotherapeutics. 2013 Jan;10(1):97-105
pubmed: 23229226
Int J Endocrinol. 2012;2012:417017
pubmed: 23251153
Crit Rev Immunol. 2013;33(3):183-202
pubmed: 23756243
Nutrients. 2013 Jul 05;5(7):2502-21
pubmed: 23857223
N Engl J Med. 2013 Nov 21;369(21):1991-2000
pubmed: 24256378
J Allergy Clin Immunol. 2014 Jun;133(6):1744-52.e1
pubmed: 24418482
Mol Cancer Ther. 2014 May;13(5):1021-31
pubmed: 24748656
Ann Neurol. 2014 May;75(5):728-38
pubmed: 24771535
Nat Rev Neurol. 2014 Aug;10(8):447-58
pubmed: 25002105
PLoS One. 2014 Dec 01;9(12):e113533
pubmed: 25436776
J Inflamm (Lond). 2015 Jan 20;12(1):3
pubmed: 25632272
Eur J Clin Invest. 2015 Jun;45(6):587-93
pubmed: 25868705
Mult Scler Relat Disord. 2015 May;4(3):234-40
pubmed: 26008940
Lancet. 2015 Sep 5;386(9997):974-81
pubmed: 26135706
N Engl J Med. 2015 Oct 15;373(16):1519-30
pubmed: 26465985
J Neuroinflammation. 2015 Dec 16;12:234
pubmed: 26669675
Am J Gastroenterol. 2016 May;111(5):712-9
pubmed: 26952579
Autoimmun Rev. 2016 Sep;15(9):900-10
pubmed: 27395031
Neurology. 2016 Sep 6;87(10):974-5
pubmed: 27511184
Steroids. 2016 Nov;115:182-192
pubmed: 27643454
Proc Natl Acad Sci U S A. 2017 Feb 28;114(9):E1678-E1687
pubmed: 28196884
Cell. 2017 Mar 9;168(6):960-976
pubmed: 28283069
Invest Ophthalmol Vis Sci. 2017 Feb 1;58(2):974-980
pubmed: 28535268
Arthritis Res Ther. 2018 Sep 20;20(1):212
pubmed: 30236152
J Steroid Biochem. 1981 Dec;15:261-8
pubmed: 6121940
Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7861-4
pubmed: 8755567
Cell. 1998 May 15;93(4):531-41
pubmed: 9604929